Ribociclib
novartis
['letrozole', 'breast', 'ts,perio,i', 'ribociclib']
proud to present right choice trial subgroup analysis by age at #asco23 in patients &lt;40 with aggressive hr+ her2- advanced #breastcancer cancer: #ribociclib + et (ofs + letrozole) pfs superior to combo chemo (hr 0.38) 
Professor: AUB Amer Univ Beirut; Head, Heme/Onc / Breast Ca; MD: ULB Bruxelles; Oncology SLRHC/Columbia U, NY; Tweets R my own/ Retweets do not mean endorsement